These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 36384351)
1. Vaccines on demand, part II: future reality. Geall AJ; Kis Z; Ulmer JB Expert Opin Drug Discov; 2023 Feb; 18(2):119-127. PubMed ID: 36384351 [TBL] [Abstract][Full Text] [Related]
2. Vaccines' New Era-RNA Vaccine. Zhou W; Jiang L; Liao S; Wu F; Yang G; Hou L; Liu L; Pan X; Jia W; Zhang Y Viruses; 2023 Aug; 15(8):. PubMed ID: 37632102 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 mRNA vaccines: Platforms and current developments. Szabó GT; Mahiny AJ; Vlatkovic I Mol Ther; 2022 May; 30(5):1850-1868. PubMed ID: 35189345 [TBL] [Abstract][Full Text] [Related]
4. Current Status and Future Perspectives on MRNA Drug Manufacturing. Webb C; Ip S; Bathula NV; Popova P; Soriano SKV; Ly HH; Eryilmaz B; Nguyen Huu VA; Broadhead R; Rabel M; Villamagna I; Abraham S; Raeesi V; Thomas A; Clarke S; Ramsay EC; Perrie Y; Blakney AK Mol Pharm; 2022 Apr; 19(4):1047-1058. PubMed ID: 35238565 [TBL] [Abstract][Full Text] [Related]
5. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism. Amanpour S Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952 [TBL] [Abstract][Full Text] [Related]
6. Research progress on the quality control of mRNA vaccines. Hu C; Bai Y; Liu J; Wang Y; He Q; Zhang X; Cheng F; Xu M; Mao Q; Liang Z Expert Rev Vaccines; 2024; 23(1):570-583. PubMed ID: 38733272 [TBL] [Abstract][Full Text] [Related]
7. Trans-Amplifying RNA Vaccines Against Infectious Diseases: A Comparison with Non-Replicating and Self-Amplifying RNA. Zimmermann L; Erbar S Methods Mol Biol; 2024; 2786():135-144. PubMed ID: 38814392 [TBL] [Abstract][Full Text] [Related]
8. Advancing mRNA technologies for therapies and vaccines: An African context. Kairuz D; Samudh N; Ely A; Arbuthnot P; Bloom K Front Immunol; 2022; 13():1018961. PubMed ID: 36353641 [TBL] [Abstract][Full Text] [Related]
9. The discovery and development of mRNA vaccines for the prevention of SARS-CoV-2 infection. Xue VW; Wong SCC; Li B; Cho WCS Expert Opin Drug Discov; 2023 Jul; 18(7):769-780. PubMed ID: 37237360 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern. Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH Elife; 2022 Feb; 11():. PubMed ID: 35191378 [TBL] [Abstract][Full Text] [Related]
11. A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity. McCafferty S; Haque AKMA; Vandierendonck A; Weidensee B; Plovyt M; Stuchlíková M; François N; Valembois S; Heyndrickx L; Michiels J; Ariën KK; Vandekerckhove L; Abdelnabi R; Foo CS; Neyts J; Sahu I; Sanders NN Mol Ther; 2022 Sep; 30(9):2968-2983. PubMed ID: 35450821 [TBL] [Abstract][Full Text] [Related]
12. Self-amplifying RNA vaccines for infectious diseases. Bloom K; van den Berg F; Arbuthnot P Gene Ther; 2021 Apr; 28(3-4):117-129. PubMed ID: 33093657 [TBL] [Abstract][Full Text] [Related]
13. Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2. Granados-Riveron JT; Aquino-Jarquin G Biomed Pharmacother; 2021 Oct; 142():111953. PubMed ID: 34343897 [TBL] [Abstract][Full Text] [Related]
14. The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines. Wei J; Hui AM Cancer Treat Rev; 2022 Jun; 107():102405. PubMed ID: 35576777 [TBL] [Abstract][Full Text] [Related]
15. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Chaudhary N; Weissman D; Whitehead KA Nat Rev Drug Discov; 2021 Nov; 20(11):817-838. PubMed ID: 34433919 [TBL] [Abstract][Full Text] [Related]
16. The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology. Ye Z; Harmon J; Ni W; Li Y; Wich D; Xu Q ACS Nano; 2023 Aug; 17(16):15231-15253. PubMed ID: 37535899 [TBL] [Abstract][Full Text] [Related]
17. Perspectives and Prospects on mRNA Vaccine Development for COVID-19. Jin L; Han Z; Zhao P; Sun K Curr Med Chem; 2022; 29(23):3991-3996. PubMed ID: 35170403 [TBL] [Abstract][Full Text] [Related]
18. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency. Anderluzzi G; Lou G; Woods S; Schmidt ST; Gallorini S; Brazzoli M; Johnson R; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y J Control Release; 2022 Feb; 342():388-399. PubMed ID: 34896446 [TBL] [Abstract][Full Text] [Related]